Biomarin Pharmaceutical Inc
LSE:0HNC
Biomarin Pharmaceutical Inc
LSE:0HNC
Price:
59.25
USD
-0.85%
Market Closed
Market Cap:
$11.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Biomarin Pharmaceutical Inc
LSE:0HNC
|
US |
|
L
|
Lubelski Wegiel Bogdanka SA
XMUN:UXX
|
PL |
|
N
|
Nestle SA
XMUN:NESR
|
CH |
|
BrainPad Inc
TSE:3655
|
JP |
|
C
|
Capita PLC
OTC:CTAGY
|
UK |
|
W
|
Wesfarmers Ltd
OTC:WFAFF
|
AU |
|
F
|
FibroGen Inc
SWB:1FG
|
US |
|
T
|
Trillion Energy International Inc
F:Z62
|
CA |
|
S
|
Schroders PLC
OTC:SHNWF
|
UK |
|
Nampak Ltd
F:NNZ0
|
ZA |
|
G
|
Globalstar Inc
SWB:P8S
|
US |
|
S
|
SSE PLC
OTC:SSEZF
|
UK |
|
B
|
BlackRock Inc
XMUN:BLQA
|
US |
|
T
|
Ternium SA
BMV:TX
|
LU |
|
GE Vernova Inc
F:Y5C
|
US |
|
ConvaTec Group PLC
LSE:CTEC
|
UK |
Multiples-Based Value
The Multiples-Based Value for 
Biomarin Pharmaceutical Inc (0HNC) under the Base Case is hidden
USD.
Compared with the current market price of 59.25 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
0HNC Multiples-Based Value
LOCKED
